Literature DB >> 29354867

Short- and long-term outcomes of surgical management of peptic ulcer complications in the era of proton pump inhibitors.

Rabea Hasadia1, Yael Kopelman1, Oded Olsha2, Ricardo Alfici1, Itamar Ashkenazi3.   

Abstract

PURPOSE: We evaluated the short-term and long-term outcomes of emergency operations for peptic ulcer (PUD) complications in a period of time in which the need for surgery is infrequent.
METHODS: Retrospective review of operated patients (2007-2015) in one medical center.
RESULTS: 81 patients were included (8.9 patients/year): 70 (86.4%) male; 11 (13.6%) female. Indications for operation were hemorrhage in 18 (22.2%), perforation in 62 (76.5%) and gastric-outlet obstruction in one (1.2%). Only 16 (19.8%) operations included a procedure to reduce gastric acid secretion. Six (7.4%) patients had a second operation for recurrent or persistent complication. Of these, two had a procedure to reduce gastric acid secretion in their first operation. 16 (19.8%) patients died during the index hospitalization. Three (3.7%) patients were rehospitalized for a PUD complication following 3-24 months. One patient, who had surgery for a second perforation 3 months following the first operation, was treated empirically for Helicobacter Pylori (HP) between the two operations. In comparison to perforation, patients with hemorrhage were older (69.9 ± 20.3 vs. 52.1 ± 19.9 years; p = 0.0015), more commonly had a history of PUD or treatment by nonsteroidal anti-inflammotry drugs (55.6 vs. 19.4%; p = 0.0054), more commonly had a procedure to reduce gastric acid secretion during their index operation (61.1 vs. 6.5%; p < 0.0001), and had a higher mortality (38.9 vs. 14.5%; p = 0.0406).
CONCLUSIONS: Mortality is high following surgery for the complications of PUD, moreso in patients undergoing surgery for hemorrhage. Reoperations and repeated hospitalizations for complications are not uncommon, even in patients who have had procedures to reduce gastric acid secretion and HP eradication.

Entities:  

Keywords:  Peptic ulcer; Peptic ulcer hemorrhage; Peptic ulcer perforation

Mesh:

Substances:

Year:  2018        PMID: 29354867     DOI: 10.1007/s00068-017-0898-z

Source DB:  PubMed          Journal:  Eur J Trauma Emerg Surg        ISSN: 1863-9933            Impact factor:   3.693


  40 in total

Review 1.  Clinical scoring systems for determining the prognosis of gastrointestinal bleeding.

Authors:  H Hussain; S Lapin; M S Cappell
Journal:  Gastroenterol Clin North Am       Date:  2000-06       Impact factor: 3.806

2.  A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology.

Authors:  F L Lanza
Journal:  Am J Gastroenterol       Date:  1998-11       Impact factor: 10.864

3.  The dangers of NSAIDs: look both ways.

Authors:  Abigail Davis; John Robson
Journal:  Br J Gen Pract       Date:  2016-04       Impact factor: 5.386

4.  Prediction of outcome using the Mannheim peritonitis index in 2003 patients. Peritonitis Study Group.

Authors:  A Billing; D Fröhlich; F W Schildberg
Journal:  Br J Surg       Date:  1994-02       Impact factor: 6.939

Review 5.  Surgical management of peptic ulcer disease in the Helicobacter era--management of bleeding peptic ulcer.

Authors:  R A Cowles; M W Mulholland
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2001-02       Impact factor: 1.719

6.  Changes in surgical treatment of peptic ulcer disease within a veterans hospital in the 1970s and the 1980s.

Authors:  D B McConnell; G C Baba; C W Deveney
Journal:  Arch Surg       Date:  1989-10

7.  Is transcatheter arterial embolization a safer alternative than surgery when endoscopic therapy fails in bleeding duodenal ulcer?

Authors:  Linas Venclauskas; Svein-Olav Bratlie; Karin Zachrisson; Almantas Maleckas; Juozas Pundzius; Claes Jönson
Journal:  Scand J Gastroenterol       Date:  2010-03       Impact factor: 2.423

8.  Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease.

Authors:  T Rokkas; A Karameris; A Mavrogeorgis; E Rallis; N Giannikos
Journal:  Gastrointest Endosc       Date:  1995-01       Impact factor: 9.427

9.  Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.

Authors:  Pradeep T Cherian; Srilekha Cherian; Pradip Singh
Journal:  Gastrointest Endosc       Date:  2007-07-20       Impact factor: 9.427

10.  Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis.

Authors:  S E Gabriel; L Jaakkimainen; C Bombardier
Journal:  Ann Intern Med       Date:  1991-11-15       Impact factor: 25.391

View more
  1 in total

1.  Massive gastric dilation caused by gastric outlet obstruction in the setting of peptic ulcer disease-A case report.

Authors:  C S Costa; N Pratas; H Capote
Journal:  Int J Surg Case Rep       Date:  2020-05-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.